|
1
|
Zitvogel L, Kepp O and Kroemer G: Immune
parameters affecting the efficacy of chemotherapeutic regimens. Nat
Rev Clin Oncol. 8:151–160. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zitvogel L, Galluzzi L, Smyth MJ and
Kroemer G: Mechanism of action of conventional and targeted
anticancer therapies: Reinstating immunosurveillance. Immunity.
39:74–88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pagès F, Berger A, Camus M, Sanchez-Cabo
F, Costes A, Molidor R, Mlecnik B, Kirilovsky A, Nilsson M, Damotte
D, et al: Effector memory T cells, early metastasis and survival in
colorectal cancer. N Engl J Med. 353:2654–2666. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Galon J, Costes A, Sanchez-Cabo F, et al:
Type, density and location of immune cells within human colorectal
tumors predict clinical outcome. Science. 313:1960–1964. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laghi L, Bianchi P, Miranda E, et al: CD3+
cells at the invasive margin of deeply invading (pT3-T4) colorectal
cancer and risk of post-surgical metastasis: A longitudinal study.
Lancet Oncol. 10:877–884. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fridman WH, Pagès F, Sautes-Fridman C and
Galon J: The immune contexture in human tumours: Impact on clinical
outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yasuda K, Nirei T, Sunami E, Nagawa H and
Kitayama J: Density of CD4(+) and CD8(+) T lymphocytes in biopsy
samples can be a predictor of pathological response to
chemoradiotherapy (CRT) for rectal cancer. Radiat Oncol. 6:492011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosenberg SA, Yang JC and Restifo NP:
Cancer immunotherapy: Moving beyond current vaccines. Nat Med.
10:909–915. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gajewski TF, Schreiber H and Fu YX: Innate
and adaptive immune cells in the tumor microenvironment. Nat
Immunol. 14:1014–1022. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poggi A, Musso A, Dapino I and Zocchi MR:
Mechanisms of tumor escape from immune system: Role of mesenchymal
stromal cells. Immunol Lett. 159:55–72. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Janeway CA Jr, Travers P, Walport M and
Shlomchik MJ: Immunobiology: The Immune System in Health and
Disease (5th). Garland Science. New York: 2001.
|
|
12
|
Morris GP and Allen PM: How the TCR
balances sensitivity and specificity for the recognition of self
and pathogens. Nat Immunol. 13:121–128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arstila TP, Casrouge A, Baron V, Even J,
Kanellopoulos J and Kourilsky P: A direct estimate of the human
alphabeta T cell receptor diversity. Science. 286:958–961. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Arstila TP, Casrouge A, Baron V, Even J,
Kanellopoulos J and Kourilsky P: Diversity of human alpha beta T
cell receptors. Science. 288:11352000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Thor Straten P, Schrama D, Andersen MH and
Becker JC: T-cell clonotypes in cancer. J Transl Med. 2:112004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hazama S, Nakamura Y, Tanaka H, Hirakawa
K, Tahara K, Shimizu R, Ozasa H, Etoh R, Sugiura F, Okuno K, et al:
A phase II study of five peptides combination with
oxaliplatin-based chemotherapy as a first-line therapy for advanced
colorectal cancer (FXV study). J Transl Med. 12:1082014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fang H, Yamaguchi R, Liu X, Daigo Y, Yew
PY, Tanikawa C, Matsuda K, Imoto S, Miyano S and Nakamura Y:
Quantitative T cell repertoire analysis by deep cDNA sequencing of
T cell receptor α and β chains using next-generation sequencing
(NGS). Oncoimmunology. 3:e9684672015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giudicelli V, Chaume D and Lefranc MP:
IMGT/GENE-DB: A comprehensive database for human and mouse
immunoglobulin and T cell receptor genes. Nucleic Acids Res.
33:D256–D261. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Langmead B and Salzberg SL: Fast
gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yousfi Monod M, Giudicelli V, Chaume D and
Lefranc MP: IMGT/JunctionAnalysis: The first tool for the analysis
of the immunoglobulin and T cell receptor complex V-J and V-D-J
JUNCTIONs. Bioinformatics. 20(Suppl 1): S379–S385. 2004. View Article : Google Scholar
|
|
21
|
Venturi V, Kedzierska K, Turner SJ,
Doherty PC and Davenport MP: Methods for comparing the diversity of
samples of the T cell receptor repertoire. J Immunol Methods.
321:182–195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ochsenreither S, Fusi A, Wojtke S, Busse
A, Nüssler NC, Thiel E, Keilholz U and Nagorsen D: Comparison of
T-cell receptor repertoire restriction in blood and tumor tissue of
colorectal cancer patients. J Transl Med. 8:352010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sherwood AM, Emerson RO, Scherer D,
Habermann N, Buck K, Staffa J, Desmarais C, Halama N, Jaeger D,
Schirmacher P, et al: Tumor-infiltrating lymphocytes in colorectal
tumors display a diversity of T cell receptor sequences that differ
from the T cells in adjacent mucosal tissue. Cancer Immunol
Immunother. 62:1453–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo W, Liao WJ, Huang YT, Shi M, Zhang Y,
Wen Q, Zhou MQ and Ma L: Normalization of T cell receptor
repertoire diversity in patients with advanced colorectal cancer
who responded to chemotherapy. Cancer Sci. 102:706–712. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou J, Ma R, Luo R, Sun Y, He X, Sun W,
Tang W and Yao X: Primary exploration of CDR3 spectratyping and
molecular features of TCR β chain in the peripheral blood and
tissue of patients with colorectal carcinoma. Cancer Epidemiol.
34:733–740. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mlecnik B, Tosolini M, Kirilovsky A,
Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman
WH, Pagès F and Galon J: Histopathologic-based prognostic factors
of colorectal cancers are associated with the state of the local
immune reaction. J Clin Oncol. 29:610–618. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagorsen D, Keilholz U, Rivoltini L,
Schmittel A, Letsch A, Asemissen AM, Berger G, Buhr HJ, Thiel E and
Scheibenbogen C: Natural T-cell response against MHC class I
epitopes of epithelial cell adhesion molecule, her-2/neu and
carcinoembryonic antigen in patients with colorectal cancer. Cancer
Res. 60:4850–4854. 2000.PubMed/NCBI
|
|
28
|
Czerkinsky C, Andersson G, Ekre HP, et al:
Reverse ELISPOT assay for clonal analysis of cytokine production.
I. Enumeration of gamma-interferon-secreting cells. J Immunol
Methods. 110:29–36. 1988. View Article : Google Scholar : PubMed/NCBI
|
